Welcome to our dedicated page for Virtus Investment Partners news (Ticker: $VRTS), a resource for investors and traders seeking the latest updates and insights on Virtus Investment Partners stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Virtus Investment Partners's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Virtus Investment Partners's position in the market.
Virtus Total Return Fund Inc. (NYSE: ZTR) announced the final results of its tender offer to acquire 10% of its outstanding shares. The Fund accepted 6,857,832 shares, representing 10% of its outstanding shares, for payment on or about May 8, 2024. A total of 23,504,666.8517 shares were properly tendered, with approximately 29.18% of the shares tendered by each stockholder accepted for payment. The purchase price of the accepted shares is 98% of the Fund's net asset value per share, equal to $5.9976 per share.
